Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracerebroventricular VGN-R08b in pediatric type 3 Gaucher disease (Phase I/II)
CTR20261727Phase 2Active
- Sponsor
- T-MAXESTATE
- Start
- Apr 2026
- Modality
- Small Molecules, AAV Vectors → Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of VGN-R08b in Gaucher disease type 3, sponsored by T-MAXESTATE. Started Apr 2026; status: active.
02
Drugs
VGN-R08b
03
Conditions
Gaucher disease type 3
Beyond the preview
Go deeper on CTR20261727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261727.